Patients Coming Off Slimming Injections Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

New research indicates that individuals who stop using new slimming jabs like semaglutide or tirzepatide may regain lost weight far faster than those who halt traditional diet and exercise plans.

Findings released in a major medical journal shows that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.

"Individuals using such medications should be informed of the potential of quick weight regain when the treatment concludes," cautioned expert Dr. Susan Jebb.

This pace of recovery implies a reversion to starting mass in about one and a half years.

Comparing Therapies

The research, which reviewed dozens of studies involving thousands of patients, contrasted the effects of these new drugs with older methods.

Scientists point out that people who lose weight through lifestyle changes alone generally see a less rapid creep back—perhaps 100 grams monthly—after stopping.

Understanding the Fast Rebound

Doctors propose the way of the jabs accounts for the heightened rebound.

The injections copy a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of the hormone levels several times higher than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' means appetite is no longer kept in check, making overeating a significant risk."

An Ongoing Issue?

Health authorities advise the injections for people with obesity-related health risks, alongside prescribed diet and exercise modifications.

Many experts argue that, due to the high risk of weight regain, the therapy should be considered ongoing.

This perspective is reinforced by drug manufacturers, who state that the findings "highlight the long-term character of excess weight," similar to managing diseases like hypertension.

User Accounts

Users who have discontinued the medication report a sudden return of appetite.

"It was like a trigger flipping and I was suddenly ravenous," recalled an individual.

This difficulty is exacerbated if patients have not developed permanent lifestyle or habit modifications during therapy.

Growing Adoption

Figures show that a significant number of adults in the UK have used these injections in the past year, with interest remaining high.

• Adoption is more common among women compared to men.
• The 40s and 50s demographic shows the highest level of interest.
• Many access the drugs through private healthcare rather than the NHS.

In conclusion, researchers stress that while the jabs are powerful tools for shedding pounds, they are not a permanent cure and maintained weight loss relies on ongoing behavioural changes.